Archive News

 

 

Congratulations to Chetanya Pandya!

Tullius_Pandya

Chetanya is the very first recipient of the Charles DeLisi Doctoral Dissertation Award.  This award will be presented annually to the author of the best doctoral dissertation in the Bioinformatics Program.  It was named after the founder of the Graduate Program in Bioinformatics, and is made possible by a generous gift from Prof. DeLisi.

 

Evan Appleton’s New Paper in Nature Methods

Evan Appleton's work with Doug Densmore's group in CIDAR (Cross-Disciplinary Integration of Design Automation Research) has been published in the current issue of Nature Methods.  Read it here: Interactive assembly algorithms for molecular cloning.  The paper has been blogged about by Nicole Rusk, and is also featured in the current issue of Nature, in a special synthetic biology section. Great work Evan!

BU Bioinformatics Admissions and Recruitment Reception

June 3, 2014  from  4:30 – 7 pm

LSEB Lobby – Life Science and Engineering Building -  24 Cummington Mall

An opportunity for prospective students to learn about the MS and PhD Programs in Bioinformatics, as well as our new MS Program, focusing on bioinformatics for translational medicine.

We will have faculty, students and staff available for informal discussions about our research, PhD fellowships, MS scholarships, curricula and the admissions process.

Who Should Attend?

Bioinformatics is an interdisciplinary field that draws from biology, systems engineering
, chemistry, genetics/genomics
, physics, mathematics/statistics and computer science, among others.  Students with a strong background in either the biological or computational sciences are encouraged to attend.

BU Bioinformatics is committed to supporting highly qualified women, racial and ethnic minorities, persons with disabilities, and other individuals who are underrepresented in STEM. Several travel grants are available for students to travel to Boston to learn about our Program.

Special Bioinformatics Seminar

Special Bioinformatics Seminar

Monday 4/28 @ 5:30 pm LSEB B01 - 24 Cummington Mall

 

Analytical Challenges in Clinical Cancer Diagnostics by NGS

Doron Lipson, PhD

Senior Director, Computational Biology Methods at Foundation Medicine in Cambridge

Dr. Lipson has over 10 years of experience in developing genomic applications. He is currently leading a team responsible for developing clinical-grade computational methods for detecting driver alterations in tumors from NGS data at Foundation Medicine. Previously, he has worked at Helicos BioSciences and at Agilent, and was a co-founder of ProteOptics, which was acquired by Bio-Rad in 2006. Dr. Lipson received his Ph.D. in Computer Science from Israel Institute of Technology, and his B.S. in Computer Science and Biology from the Hebrew University of Jerusalem.

Recent Publications

Kinase fusions are frequent in Spitz tumours and spitzoid melanomas Nature Communications / 20 January 2014

A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma Clinical Cancer Research / 1 January 2014  

BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition Clinical Cancer Research / 15 December 2013

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer Nature Medicine / 27 October 2013

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Nature Biotechnology / 20 October 2013

Relapsed classic E-cadherin (CDH1) mutated invasive lobular breast cancer demonstrates a high frequency of HER2 (ERBB2) gene mutations Clinical Cancer Research / 10 April 2013

 

Host: Simon Kasif